Gaithersburg, MD and Cambridge, MA – December 4, 2019: MaxCyte, the global cell-based therapies and life sciences company, and KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to achieve higher probabilities of success in drug development, announced today that the companies have entered into a new development and commercialization agreement. Under the agreement, […]

PALO ALTO, Calif. and BALTIMORE, Dec. 3, 2019 /PRNewswire/ — GEn1E Lifesciences Inc., a Y Combinator-backed biotech startup focused on curing inflammatory and age-related diseases, announced today that it has acquired an exclusive, worldwide and all-fields license to the University of Maryland, Baltimore’s (UMB) specific and function selective p38a kinase inhibitor program. GEn1E is developing cures […]

– Clinical and commercial agreement using MaxCyte’s recently launched ExPERT™ platform – Takes MaxCyte’s total number of partnered commercial licenses to seven CAMBRIDGE, Mass. & GAITHERSBURG, Md., (November 21, 2019)— Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, and MaxCyte, Inc., a global cell-based therapies and life sciences […]

National Biotech Facility Consulting Firm Continues to Gain Traction in Milestone Year on Heels of Recent Project Completion for United Therapeutics and Academic Medical Center in the Southeast Burtonsville, MD – September 19, 2019 – Facility Logix, a life sciences consulting firm providing best-in-class customized facility solutions and novel approaches to facility design, real estate construction and project […]

Serial Entrepreneurs of the Biohealth Capital Region A strong group of entrepreneurs ready and willing to innovate, fund and lead new bioscience companies is essential to the creation and sustainability of top-tier biohealth clusters.  It is often referenced that the BioHealth Capital Region (BHCR) lacks a deep enough pool of qualified executive talent that is […]